Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg.
This medicine is generally administered once daily with the evening meal.
The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg.
Patients who have not previously received antidiabetic drug therapy and for whom adequate glycemic control is difficult to achieve with monotherapy:
When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily.
The dose should be titrated gradually to reduce gastrointestinal adverse reactions to metformin.
For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the same dose of metformin the patient was taking or an appropriately adjusted dose therapeutically close to it. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
For patients switching from combination therapy with dapagliflozin and metformin to this medicine, the dose of this medicine may be started at the doses of dapagliflozin and metformin previously administered. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia.
The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another glucose-lowering agent. Because such a switch may cause changes in glycemic control, any change in treatment of patients with type 2 diabetes should be made under close monitoring.
This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet.
Renal impairment
No dose adjustment is necessary in patients with mild renal impairment.
For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg.
Use of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2.
If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this medicine must be discontinued immediately. Renal function should be assessed every 3~6 months.
Older adults
Because metformin is excreted by the kidneys and renal function tends to decline in older adults, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults, Patient subsection).
Improvement of glycemic control in adults with type 2 diabetes mellitus
Type 2 diabetes
blood sugar regulation abnormalities
cardiovascular disease
cardiovascular risk factors
View approved original textHide original text
This medication is used in combination with dietary and exercise therapy to aid blood sugar control in adult patients with type 2 diabetes for whom dapagliflozin and metformin are appropriate. It is especially applicable to patients with type 2 diabetes who do not have sufficient blood sugar control and have cardiovascular disease or risk factors. For detailed clinical trial information regarding the impact of dapagliflozin on the occurrence of cardiovascular events, refer to expert sources. Therefore, this medication helps to improve treatment effects by assisting in both blood sugar control and cardiovascular health management.
How to take
Adult dose
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg.
This medicine is generally administered once daily with the evening meal.
The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg.
Patients who have not previously received antidiabetic drug therapy and for whom adequate glycemic control is difficult to achieve with monotherapy:
When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily.
The dose should be titrated gradually to reduce gastrointestinal adverse reactions to metformin.
For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the same dose of metformin the patient was taking or an appropriately adjusted dose therapeutically close to it. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
For patients switching from combination therapy with dapagliflozin and metformin to this medicine, the dose of this medicine may be started at the doses of dapagliflozin and metformin previously administered. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia.
The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another glucose-lowering agent. Because such a switch may cause changes in glycemic control, any change in treatment of patients with type 2 diabetes should be made under close monitoring.
This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet.
Renal impairment
No dose adjustment is necessary in patients with mild renal impairment.
For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg.
Use of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2.
If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this medicine must be discontinued immediately. Renal function should be assessed every 3~6 months.
Older adults
Because metformin is excreted by the kidneys and renal function tends to decline in older adults, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults, Patient subsection).
Precautions
This medication is a drug for the treatment of diabetes, with one of the active ingredients being metformin hydrochloride and the other being dapagliflozin.
While rare, serious lactic acidosis may occur when taking this medication, therefore caution is advised. Lactic acidosis is a dangerous condition caused by excessive buildup of acid in the body, which can sometimes be life-threatening.
Additionally, taking this medication with insulin or sulfonylurea agents can pose a risk of hypoglycemia, meaning blood sugar may drop too low, so special care must be taken.
This medication should not be given to certain patients. For example, patients who are allergic to this medication or its ingredients, those with severely impaired kidney function, dehydration status, severe infections, very poor heart function, individuals with type 1 diabetes, pregnant or breastfeeding women, and patients genetically incapable of digesting certain sugars should not take this medication.
Patients with mildly reduced kidney function or depleted fluid volume should be cautious when taking this medication, and regular tests should be followed according to a doctor's instructions due to the potential for blood pressure drops or worsening kidney function.
During the use of this medication, there may be occurrences of genital or urinary infections, so consult a healthcare provider immediately if infection symptoms appear.
Furthermore, this medication can lower vitamin B12 levels, hence patients on long-term treatment should have their vitamin B12 levels regularly checked.
Excessive alcohol intake can increase the risk of side effects, so alcohol consumption should be avoided while on this medication.
Prior to surgery or tests involving radiographic contrast agents, this medication should be discontinued for a period of time, and it should be resumed only after confirming normal kidney function post-surgery.
Elderly patients or those with impaired kidney function need to pay extra attention and require careful monitoring for symptoms of hypoglycemia or dehydration.
Lastly, this medication should be kept out of reach of children and stored in its original container to prevent misuse or quality deterioration.
Side effects
Severe lactic acidosis
severe hypoglycemia
vulvovaginitis
balanitis
genital infection
urinary tract infection
fungal infection
hypoglycemia
decreased fluid volume
thirst
Show 85 moreCollapse
diabetic ketoacidosis
dizziness
constipation
dry mouth
lower back pain
dysuria
polyuria
nocturia
vulvar itching
genital itching
increased hematocrit
decreased kidney creatinine clearance
dyslipidemia
increased blood creatinine
increased blood urea
weight loss
ketoacidosis
urosepsis
pyelonephritis
acute kidney injury
renal dysfunction
rash
diarrhea
nausea
vomiting
decreased vitamin B12
Guillain-Barré syndrome
bacterial pneumonia
sialadenitis
tendinitis
chest pain
fever
burns
wrist fracture
gastrointestinal stromal tumor
malignant lung neoplasm
uterine fibroids
atrial fibrillation
acute cholecystitis
epigastric pain
dyspepsia
abdominal discomfort
abdominal pain
gastric ulcer
irritable bowel syndrome
salivary gland mass
toothache
headache
facial paralysis
peripheral neuropathy
sensory disturbances
drowsiness
tremors
nasopharyngitis
pharyngitis
adenoviral conjunctivitis
shingles
pneumonia
rhinitis
increased alanine aminotransferase
increased blood glucose
arthralgia
myalgia
myofascial pain syndrome
osteoarthritis
osteochondrosis
limb pain
periarticular inflammation
tendinitis
trigger finger
weakness
fatigue
peripheral edema
swelling
pain
vitamin D deficiency
hyperglycemia
urethral syndrome
cough
hyperventilation
itching
palpitations
insomnia
type 2a hyperlipidemia
sensorineural hearing loss
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.
Appearance and packaging
Appearance
Pink, biconvex, oval film-coated tablet
Package unit
30 tablets/bottle
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.